Brief: Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published Globally
May 7 (Reuters) - Icecure Medical Ltd ICCM.O :
* INDEPENDENT STUDY RESULTS IN JAPAN DEMONSTRATE ZERO (0%)
BREAST
CANCER LOCAL RECURRENCE 5 YEARS FOLLOWING TREATMENT WITH
ICECURE'S PROSENSE®, ADDING TO CONTINUED POSITIVE DATA PUBLISHED
GLOBALLY
Source text for Eikon: ID:nPn7Xrg3za
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM